Pharmacologic basis for antimicrobial therapy in newborn infants.
D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002228:Carbenicillin / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D007612:Kanamycin / Q000494:pharmacology / Q000627:therapeutic use; D007700:Kinetics; D008431:Maternal-Fetal Exchange; D010400:Penicillin G / Q000494:pharmacology / Q000627:therapeutic use; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use; D011247:Pregnancy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D007612:Kanamycin; D000667:Ampicillin; D002228:Carbenicillin; D010400:Penicillin G